SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Sonnet BioTherapeutics Q1 EPS $(0.05), Sales $5.68M

Sonnet BioTherapeutics (NASDAQ:SONN) reported quarterly losses of $(0.050) per share. The company reported $5.680 million in sales this quarter.

Benzinga · 05/18/2020 11:38

Sonnet BioTherapeutics (NASDAQ:SONN) reported quarterly losses of $(0.050) per share. The company reported $5.680 million in sales this quarter.